The neuroprotection of hydrogen sulfide against MPTP-induced dopaminergic neuron degeneration involves uncoupling protein 2 rather than ATP-sensitive potassium channels

Antioxid Redox Signal. 2012 Sep 15;17(6):849-59. doi: 10.1089/ars.2011.4507. Epub 2012 Apr 20.

Abstract

Aims: Hydrogen sulfide (H(2)S), a novel gaseous mediator, has been recognized to protect neurons from overexcitation by enhancing the activity of the adenosine triphosphate-sensitive potassium (K-ATP) channel. However, no direct evidence supports that the K-ATP channel contributes to the neuroprotective effect of H(2)S in neurodegeneration. Herein, wild-type and Kir6.2 knockout (Kir6.2(-/-)) mice were used to establish the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease (PD) so as to investigate the involvement of K-ATP channels in the neuroprotection of H(2)S.

Results: Systemic administration of sodium hydrosulfide (NaHS) (an H(2)S donor, 5.6 mg/kg/day) for 7 days rescued MPTP-induced loss of dopaminergic (DA) neurons in substantia nigra compacta of both Kir6.2(+/+) and Kir6.2(-/-) mice. Consistently, NaHS (100 μM) protected primary mesencephalic neurons against 1-methyl-4-phenylpyridinium (MPP(+))-induced cytotoxicity in both genotypes. We further found that deficiency of mitochondrial uncoupling protein 2 (UCP2), which reduces reactive oxygen species (ROS) production and functions as upstream to the K-ATP channel in determining vulnerability of DA neurons, abolished the protective effects of H(2)S against either DA neuron degeneration in the PD mouse model or MPP(+)-induced injury in primary mesencephalic neurons. Rationally, UCP2 evokes mild uncoupling, which in turn diminishes ROS accumulation in DA neurons. Furthermore, H(2)S exerted neuroprotective effect via enhancing UCP2-mediated antioxidation and subsequently suppressing ROS-triggered endoplasmic reticulum stress as well as ultimately inhibiting caspase 12-induced neuronal apoptosis.

Innovation and conclusion: H(2)S protects DA neurons against degeneration in a UCP2 rather than Kir6.2/K-ATP channel-dependent mechanism, which will give us an insight into the potential of H(2)S in terms of opening up new therapeutic avenues for PD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / pharmacology*
  • Animals
  • Blotting, Western
  • Chromatography, High Pressure Liquid
  • Dopaminergic Neurons / drug effects*
  • Dopaminergic Neurons / metabolism*
  • Hydro-Lyases / genetics
  • Hydro-Lyases / metabolism
  • Hydrogen Sulfide / pharmacology*
  • Immunohistochemistry
  • Ion Channels / genetics
  • Ion Channels / metabolism
  • KATP Channels / genetics
  • KATP Channels / metabolism*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mitochondrial Proteins / genetics
  • Mitochondrial Proteins / metabolism
  • Potassium Channels, Inwardly Rectifying / genetics
  • Potassium Channels, Inwardly Rectifying / metabolism
  • Reactive Oxygen Species / metabolism
  • Uncoupling Protein 2

Substances

  • Ion Channels
  • KATP Channels
  • Kir6.2 channel
  • Mitochondrial Proteins
  • Potassium Channels, Inwardly Rectifying
  • Reactive Oxygen Species
  • Ucp2 protein, mouse
  • Uncoupling Protein 2
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
  • Hydro-Lyases
  • lactate dehydratase
  • Hydrogen Sulfide